Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome

Inclusion Criteria: 1. aged 18-65; 2. able to provide written informed consent; 3. have a diagnosis of Tourette's syndrome according to the Statistical Manual of Mental Disorders-Fourth Edition-Text Revised (DSM-IV-TR) criteria and confirmed by the Mini-International Neuropsychiatric Interview Chinese version 5.0; 4. with a YGTSS of at least 35 for at least 12 months before surgery, while YGTSS- Total Motor≥15; 5. must have failed conventional medical treatment at adequate therapeutic doses of three classes of medication lasting for at least three months; 6. must not be suitable for behavioural intervention or that this intervention is inappropriate or unsuccessful; 7. have been on stable comorbid conditions without suicidal ideation for at least six months. Exclusion Criteria: 1. presence of other psychotic disorders; 2. have a treatment history that includes electroconvulsive therapy (ECT), modified electroconvulsive therapy (MECT), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), DBS, and transcranial magnetic stimulation (TMS); 3. presents a suicide risk (defined as a HAMD-17 score of ≥3 on suicide-related items); 4. experience difficulty in effectively communicating with investigators; 5. with a history of traumatic brain injury (TBI); 6. with intracranial or cardiovascular stents; 7. substance abuse within the past six months; 8. unstable neurological or coagulation disorders; 9. women who are pregnant, lactating, or of childbearing potential who refuse the use of reliable contraception during the study; 10. have been involved in other clinical studies within three months before enrollment in this study; 11. any conditions considered by the study group.